Estimating the Population Impact of Introducing Stereotactic Ablative Radiation Therapy for Stage I NSCLC in Canada

被引:0
|
作者
Louie, A. V. [1 ,2 ]
Rodrigues, G. [3 ]
Palma, D. A. [3 ]
Senan, S. [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] London Reg Canc Program, London, ON, Canada
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词
D O I
10.1016/j.ijrobp.2014.05.1767
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2959
引用
收藏
页码:S588 / S588
页数:1
相关论文
共 50 条
  • [21] Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries
    Damhuis, R.
    Senan, S.
    Khakwani, A.
    Harden, S.
    Helland, A.
    Strand, T-E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] Impact of Tumor Attachment to the Pleura Measured by a Pretreatment CT Image on Outcome of Stage I NSCLC Treated With Stereotactic Body Radiation Therapy
    Yamamoto, T.
    Kadoya, N.
    Takahashi, N.
    Matsushita, H.
    Shirata, Y.
    Sugawara, T.
    Kubozono, M.
    Umezawa, R.
    Abe, K.
    Fujimoto, S.
    Ishikawa, Y.
    Kozumi, M.
    Takeda, K.
    Jingu, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S614 - S615
  • [23] Body Stereotactic Radiation versus modern Surgery for the Treatment of Stage I NSCLC
    Guckenberger, Matthias
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (03) : 315 - 318
  • [24] Stereotactic radiotherapy (SRT) of NSCLC stage I
    Zimmermann, F
    Geinitz, H
    Schill, S
    Jeremic, B
    Molls, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 16 - 16
  • [25] Salvage Radiation for Mediastinal Relapse After Treatment With Accelerated Hypofractionated Radiation Therapy (AHRT) or Stereotactic Body Radiation Therapy (SBRT) for Stage I/II NSCLC
    Lester, S. C.
    Kilburn, J. M.
    Lucas, J. T.
    Munley, M. T.
    Blackstock, A. W.
    Kearns, W. T.
    Hinson, W. H.
    Miller, A. A.
    Petty, W. J.
    Urbanic, J. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S543 - S544
  • [26] A Dosimetric Model for Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy for Stage I Non-small Cell Lung Cancer
    Xiang, Z.
    Hess, K.
    Zhang, X.
    Liang, S.
    Chang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S557 - S557
  • [27] Stereotactic ablative radiation therapy in metastatic prostate cancer
    Bazyar, Soha
    Mannuel, Heather
    Tran, Phuoc T.
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (03) : 180 - 185
  • [28] Stereotactic Ablative Radiation Therapy for Primary Lung Tumors
    Heinzerling, John H.
    Kavanagh, Brian
    Timmerman, Robert D.
    CANCER JOURNAL, 2011, 17 (01): : 28 - 32
  • [29] Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases
    Sutera, Philip
    Kalash, Ronny
    Clump, David A.
    D'Ambrosio, David
    Mihai, Alina
    Burton, Steven A.
    Heron, Dwight E.
    ADVANCES IN RADIATION ONCOLOGY, 2019, 4 (01) : 57 - 62
  • [30] Stereotactic ablative body radiation therapy (SABR) in NSW
    Elizabeth R. Claridge Mackonis
    Nicholas Hardcastle
    Annette Haworth
    Physical and Engineering Sciences in Medicine, 2020, 43 : 641 - 650